Oligopeptide Inhibitors of HIV-Induced Syncytium Formation

No abstract is available for this paper.

• Publication year

  1990

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  1990-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1089/aid.1990.6.1289PMID 2078410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The env Protein of an Infectious Noncytopathic HIV-2 Is Deficient in Syncytium Formation

  1990cited by this paper
• Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.

  1990cited by this paper
• Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1

  1989cited by this paper
• Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing

  1989cited by this paper
• Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV.

  1989cited by this paper
• Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells

  1989cited by this paper
• Binding of cholesterol and inhibitory peptide derivatives with the fusogenic hydrophobic sequence of F-glycoprotein of HVJ (Sendai virus): possible implication in the fusion reaction.

  1988cited by this paper
• The molecular biology of the AIDS virus.

  1988cited by this paper
• Expression of the spleen focus-forming virus envelope gene in a polarized epithelial cell line.

  1988cited by this paper
• In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity

  1988cited by this paper
• Effects of viral chemotherapeutic agents on membrane properties. Studies of cyclosporin A, benzyloxycarbonyl-D-Phe-L-Phe-Gly and amantadine.

  1987cited by this paper
• Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus.

  1987cited by this paper
• Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.

  1987cited by this paper
• Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus

  1986cited by this paper
• Synthetic peptide analogs of apolipoproteins.

  1986cited by this paper
• Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

  1985cited by this paper
• Nucleotide sequence of the AIDS virus, LAV.

  1985cited by this paper
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

  1985cited by this paper
• Fusion mutants of the influenza virus hemagglutinin glycoprotein.

  1985cited by this paper
• Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action.

  1983cited by this paper
• Membrane fusion proteins of enveloped animal viruses

  1983cited by this paper
• Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution

  1981cited by this paper
• The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses.

  1980cited by this paper
• Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides.

  1980cited by this paper
• The effect of a carbobenzoxy tripeptide on the biological activities of measles virus.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Potential antiviral agents. Carbobenzoxy di- and tripeptides active against measles and herpes viruses.

  1968cited by this paper
• Antiviral activity of carbobenzosy di- and tripeptides on measles virus.

  1968cited by this paper
• EXPERIENCES IN DEVELOPING POTENTIAL ANTIVIRAL COMPOUNDS

  1965cited by this paper

• SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection

  2023cites this paper
• Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design

  2021influential citation
• Peptide-based Fusion Inhibitors for Preventing the Six-helix Bundle Formation of Class I Fusion Proteins: HIV and Beyond.

  2021cites this paper
• The three lives of viral fusion peptides

  2014cites this paper
• Searching for Recursively Defined Generic Chemical Patterns in Nonenumerated Fragment Spaces

  2013cites this paper
• The potential for antimicrobial peptides to improve fish health in aquaculture

  2012cites this paper
• Searching for Substructures in Fragment Spaces

  2012cites this paper
• Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy.

  2011cites this paper
• Membrane-transferring regions of gp41 as targets for HIV-1 fusion inhibition and viral neutralization.

  2011cites this paper
• Peptide inhibition of human cytomegalovirus infection

  2011cites this paper
• Role of lipids in virus replication.

  2011cites this paper
• Expression plasmids are only useful for the investigation of co-receptor tropism and fusion capacity of short HIV-1 envelope domains.

  2010cites this paper
• SPECIAL FOCUS: THE ROLE OF TRANSMEMBRANE DOMAINS IN ADHESION

  2010cites this paper
• Current Peptide HIV Type-1 Fusion Inhibitors

  2009cites this paper
• Antimicrobial peptides as model molecules for the development of novel antiviral agents in aquaculture.

  2009cites this paper
• Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission

  2008cites this paper
• Ribonucleic Acid Viruses: Antivirals for Human Immunodeficiency Virus

  2007cites this paper
• Oligopeptidos no proteolizables inhibidores dela glicoproteina gp41 del virus del sida

  2006cites this paper
• Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein

  2006cites this paper
• Hexapeptides that interfere with HIV‐1 fusion peptide activity in liposomes block GP41‐mediated membrane fusion

  2006cites this paper
• Inhibition of HIV-1 Envelope Glycoprotein-mediated Cell Fusion by a DL-Amino Acid-containing Fusion Peptide

  2004cites this paper
• Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development.

  2004cites this paper
• Are fusion peptides a good model to study viral cell fusion?

  2003cites this paper
• Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41.

  2003cites this paper
• Inhibitory Activity of Synthetic Peptide Antibiotics on Feline Immunodeficiency Virus Infectivity In Vitro

  2002cites this paper
• Peptide and non-peptide HIV fusion inhibitors.

  2002cites this paper
• Salmonid viral haemorrhagic septicaemia virus: fusion-related enhancement of virus infectivity by peptides derived from viral glycoprotein G or a combinatorial library.

  2002influential citation
• Characterization of antigens expressed in normal baboon trophoblast and cross-reactive with HIV/SIV antibodies.

  1999cites this paper
• Structure, binding and neutralization of VHSV with synthetic peptides.

  1999cites this paper
• Destabilization and fusion of zwitterionic large unilamellar lipid vesicles induced by a beta-type structure of the HIV-1 fusion peptide

  1998cites this paper
• Efficacy of Fusion Peptide Homologs in Blocking Cell Lysis and HIV-Induced Fusion

  1998cites this paper
• Fusion Peptides Derived from the HIV Type 1 Glycoprotein 41 Associate within Phospholipid Membranes and Inhibit Cell-Cell Fusion

  1997cites this paper
• Membrane Fusion Induced by the HIV Type 1 Fusion Peptide: Modulation by Factors Affecting Glycoprotein 41 Activity and Potential Anti-HIV Compounds

  1997cites this paper
• Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor

  1996cites this paper
• The receptor for HIV: dissection of CD4 and studies on putative accessory factors.

  1996cites this paper
• Antivirals That Target the Amino-Terminal Domain of HIV Type 1 Glycoprotein 41

  1995cites this paper
• Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion

  1995cites this paper
• Fusogenic Activity of Amino-Terminal Region of HIV Type 1 Nef Protein

  1994cites this paper
• Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.

  1994cites this paper
• Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1

  1994cites this paper
• A murine monoclonal antibody (RV3-27) raised against isolated human placental endogenous retroviral particles and reactive with syncytiotrophoblast.

  1994cites this paper
• Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.

  1994cites this paper
• Enhancement of bovine leukemia virus-induced syncytia formation by di- and tripeptides.

  1993cites this paper
• Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein

  1993cites this paper
• The Retroviridae

  1993cites this paper
• Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein.

  1993cites this paper
• The Amino-Terminal Peptide of HIV-1 gp41 Interacts with Human Serum Albumin

  1993cites this paper
• A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion

  1993cites this paper
• The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation.

  1992cites this paper
• Cell-specific envelope glycosylation distinguishes FIV glycoproteins produced in cytopathically and noncytopathically infected cells.

  1992cites this paper
• HIV and tropism: implications for pathogenesis.

  1991cites this paper